Literature DB >> 18775514

Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?

Cynthia L Jordan1, Andrew P Lieberman.   

Abstract

Kennedy disease (KD, or spinal and bulbar muscular atrophy) is caused by a CAG/polyglutamine expansion in the androgen receptor (AR) gene. Both motoneurons and muscles are affected by KD, but where mutant ARs act to initiate this disease is not clear. We discuss recent insights into this disease with two main themes. (1) KD is androgen-dependent, suggesting that blocking androgen action may be an effective treatment. (2) Androgens may trigger KD by acting in muscles, which indirectly affects the motoneurons, suggesting that blocking AR function in muscles may rescue motoneurons from disease and provide an effective treatment. Future research will provide a better understanding of how androgens trigger KD and the relative contributions of motoneurons versus muscles in this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775514      PMCID: PMC2603477          DOI: 10.1016/j.coph.2008.08.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  38 in total

1.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.

Authors:  Masahiro Waza; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Chen Sang; Fumiaki Tanaka; Akira Inukai; Manabu Doyu; Gen Sobue
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

3.  Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; D B Roling; A E Harding; C L Warner; R Spiegel; I Hausmanowa-Petrusewicz; W C Yee; K H Fischbeck
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

4.  X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neurophysiological, neuropathological, neuropsychological and molecular study of a large family.

Authors:  D Guidetti; E Vescovini; L Motti; E Ghidoni; F Gemignani; A Marbini; M C Patrosso; A Ferlini; F Solime
Journal:  J Neurol Sci       Date:  1996-02       Impact factor: 3.181

5.  Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

Authors:  W R Kennedy; M Alter; J H Sung
Journal:  Neurology       Date:  1968-07       Impact factor: 9.910

6.  X-linked recessive bulbospinal neuronopathy. A clinicopathological study.

Authors:  G Sobue; Y Hashizume; E Mukai; M Hirayama; T Mitsuma; A Takahashi
Journal:  Brain       Date:  1989-02       Impact factor: 13.501

7.  Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.

Authors:  Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Masahiro Waza; Chen Sang; Yuji Nakagomi; Yasushi Kobayashi; Fumiaki Tanaka; Manabu Doyu; Akira Inukai; Mari Yoshida; Yoshio Hashizume; Gen Sobue
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

8.  Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

Authors:  Ken-ichi Takeyama; Saya Ito; Ayako Yamamoto; Hiromu Tanimoto; Takashi Furutani; Hirotaka Kanuka; Masayuki Miura; Tetsuya Tabata; Shigeaki Kato
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

9.  The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator.

Authors:  P W Hsiao; D L Lin; R Nakao; C Chang
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

10.  Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy.

Authors:  M Li; S Miwa; Y Kobayashi; D E Merry; M Yamamoto; F Tanaka; M Doyu; Y Hashizume; K H Fischbeck; G Sobue
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

View more
  23 in total

1.  Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Katherine Halievski; Laura Vicente; Youfen Xu; Donald Zeolla; Jessica Poort; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

2.  Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

3.  A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability.

Authors:  Hong Xiao; Zhigang Yu; Yipin Wu; John Nan; Diane E Merry; JoAnn M Sekiguchi; David O Ferguson; Andrew P Lieberman; Gregory R Dressler
Journal:  Hum Mol Genet       Date:  2012-06-26       Impact factor: 6.150

4.  Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Sandra M Troxell-Smith; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurodegener Dis       Date:  2010-08-04       Impact factor: 2.977

Review 5.  Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

Authors:  Luc Dupuis; Andoni Echaniz-Laguna
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

Review 6.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

7.  Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.

Authors:  Andrew P Lieberman; Zhigang Yu; Sue Murray; Raechel Peralta; Audrey Low; Shuling Guo; Xing Xian Yu; Constanza J Cortes; C Frank Bennett; Brett P Monia; Albert R La Spada; Gene Hung
Journal:  Cell Rep       Date:  2014-04-16       Impact factor: 9.423

8.  Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.

Authors:  Youfen Xu; Katherine Halievski; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; S Marc Breedlove; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

9.  Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.

Authors:  Isabella Palazzolo; Conor Stack; Lingling Kong; Antonio Musaro; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; J Paul Taylor; Charlotte J Sumner; Kenneth H Fischbeck; Maria Pennuto
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

10.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.